首页> 外国专利> TREATMENT OF MULTIPLE SCLEROSIS BY COMBINATION OF LACHINIMODA AND FINGOLIMODA

TREATMENT OF MULTIPLE SCLEROSIS BY COMBINATION OF LACHINIMODA AND FINGOLIMODA

机译:衣原体和芬戈莫达联合治疗多发性硬化症

摘要

This invention relates to a method of treating a subject suffering from multiple sclerosis or exhibiting signs of a clinically isolated syndrome, comprising administering to the subject laechinimus as an adjunct therapy to fingolimod or in combination with it. The invention also relates to a kit and a pharmaceutical composition comprising lachinimide and fingolimod for the treatment of a subject suffering from multiple sclerosis or showing signs of a clinically isolated syndrome. This invention also relates to lachinimode for use as an additional therapy or in combination with fingolimod in the treatment of a subject suffering from multiple sclerosis or showing signs of a clinically isolated syndrome. This invention also relates to the use of lachinimod and fingolimod in the preparation of a combination for treating a subject suffering from multiple sclerosis or exhibiting signs of a clinically isolated syndrome.
机译:本发明涉及一种治疗患有多发性硬化症或表现出临床分离的综合症迹象的受试者的方法,该方法包括给予该受试者鞘脂作为芬戈莫德的辅助疗法或与之联合使用。本发明还涉及用于治疗患有多发性硬化症或表现出临床分离的综合症的受试者的包含拉奇酰亚胺和芬戈莫德的试剂盒和药物组合物。本发明还涉及用于额外治疗或与芬戈莫德组合用于治疗患有多发性硬化症或显示出临床分离的综合症迹象的受试者的扁桃体模式。本发明还涉及拉希莫德和芬戈莫德在制备用于治疗患有多发性硬化症或表现出临床分离的综合症状的受试者的组合中的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号